Original paper

De-osteogenic-differentiated mesenchymal stem cells accelerate fracture healing by mir-92b

Volume: 27, Pages: 25 - 32
Published: Mar 1, 2021
Abstract
Mesenchymal stem cells (MSCs) are promising targets for therapeutic use in regenerative medicine and tissue engineering. In the previous study, we have found that MSCs could be reverted to a primitive stem cell population after in vitro induction of osteogenic and de-osteogenic differentiation (de-osteogenic differentiated MSCs, De-Os-MSCs). De-Os-MSCs showed improved cell survival and osteogenic potential. However, the underlying mechanism and...
Paper Details
Title
De-osteogenic-differentiated mesenchymal stem cells accelerate fracture healing by mir-92b
Published Date
Mar 1, 2021
Volume
27
Pages
25 - 32
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.